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Chapter	1.	Introduction	and	objectives	
	
This work focuses on the investigation of the bioactivity, biodegradation 
behaviour and uptake/release properties of porous zinc oxide (ZnO) thin films 
deposited by sputtering technique. The final aim consists of coupling all these 
properties into a single platform, that would result into novel ZnO-based 
biomaterials for tissue engineering and drug delivery applications.  
 
In the first part of the work, the interactions of the porous ZnO structures with 
Simulated Body Fluid (SBF) and the medium for cell culture (eMEM) have been 
investigated for studying their bioactivity and biodegradation. In the case of the 
bioactivity study, the porous ZnO samples have been also coated with graphene 
oxide (GO) flakes, in order to investigate the influence of GO on the bioactivity of 
porous ZnO. 
 
As a second part, this thesis work is also focused on the investigation of porous 
ZnO films for drug delivery applications. Rhodamine-B has been used as a 
fluorescent molecule for studying the capacity of porous ZnO thin films to uptake 
and further release molecules, for future drug delivery applications. 
 
The experimental activity has been focused on the implementation of the 
experiments for evaluating the bioactive and biodegradation properties of the 
ZnO samples when interacting with the media mentioned above (SBF and 
eMEM). Each sample has been properly investigated in terms of morphology, 
crystal structure and chemical composition. The activities have been developed 
at the Dipartimento di Scienza Applicata e Tecnologia (DISAT) of Politecnico di 
Torino, specifically at the TNH Research Lab of Professor Valentina Cauda and 
BOOST Research Lab of Professor Chiara Vitale Brovarone. 
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The basic scheme of this thesis can be summarized as follows. Chapter 2 
provides a brief background theory introduction, especially focused on a general 
description of the bioactivity, biocompatibility and antibacterial properties of ZnO 
and GO, hydroxyapatite (HAp) precipitation phenomena, and finally SBF solution 
and eMEM. This is followed by Chapter 3, reporting a description of the materials 
and methods followed to prepare and characterize all the investigated samples, 
as well as to study the bioactivity, biodegradation and uptake/release abilities. It 
is also reported a description of the physicochemical principles and the 
characterization setups that have been used in this thesis. All the experimental 
results are summarized in Chapter 4. Chapter 5 reports the main conclusions of 
the thesis work. 
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Chapter	2.	Background	theory	
	
The aim of this chapter is to introduce and describe the materials used in this 
thesis work. The attention will be focused on their bioactivity, biodegradability and 
biocompatibility.  
 
2.1	Tissue	engineering	
Tissue engineering (TE) is a process belonging to regenerative medicine, 
consisting of the combination of several strategies to improve and/or repair 
biological tissues. TE strategies involve three major elements: cells, signalling 
molecules, and natural or artificial scaffolds. A scaffold is a structure of artificial 
or natural materials on which tissue is grown to mimic a biological process outside 
the body or to replace a disease or damaged tissue inside the body. Scaffolds for 
use in regenerative medicine provide the base for the repopulation and 
specialization of stem cells, blood vessels and extracellular matrices. In general, 
the surface morphology of the scaffold strongly affects the attachment of 
surrounding cells and tissues after implantation. Recently [1], nanomaterials have 
been investigated for use as biomaterials. Nanostructures at the surface of the 
underlying material enhance some bioactivities due to quantum size effects and 
their large surface area. Thanks to the combination of these properties the 
contact between regenerative cells or tissues and the nanostructures can be 
beneficial for promoting cell physiological proliferation or regeneration.  
For example, previous studies [2] reported that ZnO containing nano-
hydroxyapatite/chitosan cement is a promising material to enhance bone 
regeneration in osseous defect sites. Therefore, our hypothesis was that soaking 
ZnO samples into SBF solution and medium for cell culture would provide 
precipitation of hydroxyapatite (HAp) to the scaffold. Also, by modifying the 
sample using GO coating, there was expected to obtain a further enhancement 
of bioactive and drug delivery properties. 
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2.2	Zinc	oxide	
	
Zinc Oxide is a semiconductor of the II-IV group [3] showing several favourable 
properties. It has a wide band gap energy of 3.37 eV, a strong room-temperature 
luminescence, absorption of light in the UV range, a high electron mobility and 
high thermal conductivity [4, 5]. Moreover, it shows biocompatibility and low 
impact on the environment when being disposed at the end of its life cycle [6]. 
Among semiconductors, ZnO is one of the most investigated thanks to the 
possibility of combining its semiconducting behaviour with its promising catalytic, 
electrical, optical and piezoelectric properties [6]. Furthermore, it can be easily 
synthesized in a large amount of shapes and sizes. Also, it can be deposited 
using various methods including: physical or chemical vapour deposition (PVD or 
CVD), pulsed laser deposition, radio frequency (RF) magnetron sputtering, etc. 
 
ZnO has a wurtzite crystal structure at ambient conditions, showing a hexagonal 
unit cell with two lattice parameters, a and c. Figure 1 clearly shows that the 
structure is composed of two interpenetrating hexagonal closed packed (hcp) 
sublattices, in which each consist of one type of atom (Zn or O) displaced with 
respect to each other along the threefold c-axis. It can be simply explained 
schematically as a number of alternating planes stacked layer-by-layer along the 
c-axis direction and composed of tetrahedrally coordinated Zn2+ and O2−. The 
tetrahedral coordination of ZnO gives rise to the non-centrosymmetric structure. 
In wurtzite hexagonal ZnO, each anion is surrounded by four cations at the 
corners of the tetrahedron, which shows the tetrahedral coordination and hence 
exhibits the sp3 covalent-bonding. The two important characteristics of the 
wurtzite structure are the noncentral symmetry and polar surfaces. 
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Figure	1:	The	hexagonal	wurtzite	structure	model	of	ZnO.	The	tetrahedral	coordination	of	Zn-O	is	shown.	
O	atoms	are	shown	as	larger	white	spheres	while	the	Zn	atoms	are	smaller	brown	spheres	
	
Reflecting the basic properties of ZnO, oxide nanoparticles have antibacterial 
properties and for this reason they are added to materials such as cotton, rubber, 
oral care products, and food packaging [7]. We mentioned ZnO nanoparticles 
because some studies demonstrate that these particles exhibit both qualitatively 
and quantitatively better antibacterial properties than bulk ZnO with a particle size 
of 2 μm. So, ZnO exhibit strong activity even when administered in small 
amounts. The activity is quantitatively evaluated by studying the growth medium 
caused by the bacterial metabolism. As ZnO is an antibacterial material, when 
administered, there is shown a bacterial growth inhibition. As smaller is the ZnO 
nanoparticle the most growth inhibition is obtained. The considerable 
antibacterial activity ZnO is attributed to the generation of reactive oxygen 
species on the surface of this oxide, studied by a conductometry, which is method 
that monitors the capability of the analyte to conduct an electrical current [8].  
The advantage of using this metal oxide as antimicrobial agent is that it contains 
the following mineral elements essential to humans: calcium, phosphorous, 
magnesium, zinc, chlorine and others. Those elements are called essential to 
humans because without them our body won’t function properly. For example: 
calcium is needed for the construction and maintenance of bone and normal 
function of nerves and muscles and phosphorous is an important constituent of 
adenosine triphosphate.  
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Inorganic nanocrystalline metal oxides are particularly interesting because they 
can be prepared with extremely high surface areas, and are more suitable for 
biological applications. The advantages of inorganic antibacterial materials over 
organic antibacterial materials are that the former show superior durability, less 
toxicity and greater selectivity and heat resistance. ZnO has been extensively 
studied as antimicrobial agent due to its photocatalytic activity under UV light [9] 
[10]. ZnO can highly absorb UV light and it has a better response to UV light, thus 
its conductivity dramatically enhances, and this feature significantly activates the 
interaction of ZnO with bacteria.  
 
Bioactivity of ZnO nanomaterials have been demonstrated by studying the 
antimicrobial activity of suspensions with various particle sizes. The bioactivity of 
smaller particles is attributed to the higher surface area to volume ratio. For 
smaller ZnO nanoparticles, more particles are needed to cover a bacterial colony 
(2 μm) which results in the generation of a larger number of active oxygen 
species, which kill bacteria more effectively 
 
One of the most important features of ZnO nanomaterials is biodegradability. Zn2+ 
is an indispensable trace element for adults and it is involved in various aspects 
of metabolism. Chemically, the surface of ZnO is rich in -OH groups, which can 
be readily functionalized by various surface decorating molecules [11, 12]. ZnO 
can slowly dissolve in both acidic (e.g. in the tumour cells and tumour 
microenvironment) and strong basic conditions if the surface is in direct contact 
with the solution [13].  
 
Also, ZnO nanomaterials are versatile nanoplatforms for drug delivery 
applications, due to their large surface area, versatile surface chemistry, 
phototoxic effect, among others. In vitro studies have shown that ZnO 
nanoparticles can be highly toxic to cancer cells [14] or bacteria and leukemic T 
cells [15]. Therefore, ZnO nanomaterials have been investigated as drug/gene 
delivery vehicles, and also studied for cancer therapy. 
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For applications of nanomaterials in biomedicine, the biocompatibility is always a 
concern. Even though ZnO has been approved for cosmetic uses, the detailed 
toxicological profile and the mechanism of cytotoxicity for ZnO nanomaterials is 
not clear. Many studies have focused on the biocompatibility of ZnO 
nanomaterials without surface coating/modifications. For example, it was 
reported that ZnO nanoparticles showed cytotoxic effect above certain 
concentrations and the toxicity was pH dependent, due to the increased 
concentration of Zn2+ in the culture medium or inside cells from dissolved ZnO 
[16]. Nonetheless, such leakage of ionic Zn2+ into the biological system from 
dissolution of ZnO can perhaps be well-tolerated since ~10 mg/day of Zn2+ is 
needed for adults. Meanwhile, other reports have shown that ZnO nanomaterials 
were nontoxic and preferentially toxic to bacteria or cancer cells [15, 14] which 
could be advantageous for both antibacterial and cancer therapy applications. 
 
Surface modification of nanomaterials plays a crucial role for potential biomedical 
applications. It has been demonstrated that the biocompatibility of ZnO 
nanomaterials could be improved by slowing down the dissolution rate through 
Fe doping [17] or surface capping [18].  
 
There are different types of ZnO nanostructures as nanoparticles, nanorings, 
nanowires, depending on the desirable application. 
 
	
Figure	2:	A	collection	of	nanostructures	of	ZnO	synthesized	under	controlled	conditions	by	thermal	
evaporation	of	solid	powders.	Most	of	the	structures	presented	can	be	produced	with	100%	purity	[19].	
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Nanoparticles are essentially a varied form of basic elements derived by altering 
their atomic and molecular properties of elements. ZnO nanoparticles exhibit 
antibacterial, anti-corrosive, antifungal and UV filtering properties [20].  
 
In a recent study [21], ZnO nanoparticles were synthesized using various routes. 
The sol–gel method proved a successful synthetic route in terms of its cost, ease 
of handling, reliability, repeatability, and environmental friendliness. Moreover, 
with detailed review, it is conﬁrmed that the various applications of ZnO 
nanoparticles depend upon the control of both physical and chemical properties 
such as size, size distribution, shape, surface state, crystal structure and 
organization onto a support. In addition, these factors mainly depend upon the 
synthetic method. Therefore, shape, size and dispersity can be controlled by 
tuning different parameters during the synthesis process, e.g., the precursor type 
and concentration, types of capping molecule, types of solvent, reaction time, and 
reaction temperature. Application of ZnO nanoparticles in the biological realm 
requires high quality ZnO nanoparticles in aqueous solution at neutral pH and 
physiological temperature, because biomolecules are very sensitive to changes 
in temperature and pH. In addition, relatively small size, ease of transport within 
tissues/organs, ability to cross plasma membranes, and potential targeting of 
biologically active molecules will facilitate biomedical applications of 
nanoparticles in the ﬁeld of medicine.  
 
ZnO nanowires have a typical length that can vary from 100 μm to 1 mm and the 
diameter is in the range of 50-500 nm. The porous structure of the ZnO nanowires 
is apparent. The high-porosity, single-crystal wire-like structures have potential 
applications as filters, catalyst supports, and gas sensors. 
 
Highly oriented and transparent ZnO thin films have significally been researched 
because of their potential application in transparent electrode in displays, window 
layers in solar cells, field emitters, ultraviolet laser emission, photodetectors, bio-
sensors, etc. 
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 ZnO thin films can be prepared by techniques such as thermal oxidation, 
chemical vapour deposition, molecular beam epitaxy and pulsed laser deposition. 
The technique of Radio Frequency (RF) sputtering has drawn considerable 
attention for ZnO film fabrication since the resulting film properties can be 
controlled by changing the sputtering conditions such as substrate temperature, 
deposition time, pressure, and RF power.  
 
In this thesis porous ZnO thin films have been the material of the samples used. 
Made by a huge amount of ZnO nanoparticles interconnected to each others, this 
is the reason why they are considered nano objects as well. 
 
2.3	Graphene	oxide	as	a	coating		
	
Graphene is a carbon based material that can be viewed as a one atom thick 
sheet of graphite. Because high quality sheets of graphene are often prepared 
by chemical vapour deposition (CVD) [22] [23], which requires expensive 
equipment, many groups have looked at using graphene oxide (GO) as a solution 
processable alternative for the preparation of graphene-like materials [24] [25] 
[26]. Indeed, graphene oxide can be reduced in solution and as a thin film using 
a variety of reducing conditions, and reduction converts the graphene oxide into 
a material that has a large enhancement in electrical conductivity [26] [27]. In 
addition to its use in making reduced graphene oxide for electronic devices, 
graphene oxide has been used in catalytic oxidation, energy storage, cell imaging 
and drug delivery applications, as well as biosensors.  
	
Figure	3:	Chemical	structure	of	graphene	(a),	graphene	oxide	(b)	and	reduced	graphene	oxide	(c)	
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Since, in 2008, the use of graphene oxide (GO) as an efficient nanocarrier for 
drug delivery was reported [28] a lot of interesting work has been carried out to 
explore the use of graphene for widespread biomedical applications, ranging from 
drug/gene delivery, biological sensing and imaging, antibacterial materials, to 
biocompatible scaffold for cell culture. The intensive research on the 
bioapplications of graphene and its derivatives is due to many fascinating 
properties, such as high specific surface area (2630 m2/g), exceptional electronic 
conductivity (mobility of charge carriers, 200,000 cm2 V-1 s-1), thermal conductivity 
(~5000 W/m/K), mechanical strength (Young's modulus, ~1100 Gpa) of 
graphene, and, intrinsic biocompatibility, low cost and scalable production, and 
facile biological/chemical functionalization of GO [29, 30]. 
For using GO in biomedical applications it’s essential to know its toxicity. Recent 
studies have demonstrated some cellular cytotoxicity of graphene that may cause 
less cellular adhesion and induce cellular apoptosis. Nevertheless, by introducing 
functional groups on graphene surface, the interaction between GO and tissue or 
cells and the generation of reactive species of oxygen is reduced, due to the 
presence of carboxylic, epoxy and hydroxide groups. So, it is necessary to 
functionalized GO layers in order to use it in biomedical applications [31]. 
As it is mentioned above, GO can promote biological interactions due to its many 
surface functional groups (e.g. hydroxyl, epoxide, and carbonyl). Several 
investigators have reported that GO can serve as a carrier for drugs and other 
biomolecules. In addition, GO regulates the proliferation and differentiation of 
cultured mesenchymal stem cells and improves the properties of scaffolds. 
Subcutaneous implant tests showed that low concentrations of GO scaffold 
enhances cell in-growth and is highly biodegradable, whereas high 
concentrations of GO coating resulted in adverse biological effects. 
Consequently, scaffolds modified with a suitable concentration of GO are useful 
as a bioactive material for tissue engineering [32]. 
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The behaviour of Zinc Oxide porous thin films and ZnO thin films coated with GO 
in Simulated Body Fluid have been investigated in order to study the bioactivity 
and biodegradation of both materials. The main interest falls on the possibility of 
using this material as a drug delivery system. 
 
2.4	Hydroxyapatite		
	
Hydroxyapatite (HAp) is a material belonging to the calcium phosphate ceramics. 
HAp exhibits an excellent biocompatibility and osteogenic potential to promote 
tissue adhesion and bone growth. Therefore, its formation is a symbol of 
bioactivity since this material has been studied as a biocompatible material for 
the reconstruction and filling of bone tissue. The composition of HAp, 
Ca10(PO4)6(OH)2, closely resembles the one of the mineral component of native 
bone, i.e. biological apatite, a calcium deficient, carbonate-substituted non-
stoichiometric hydroxyapatite [33]. A nanocrystalline structure and a rod-like 
morphology are two further distinct features that contribute to its unique biological 
functionality under physiological conditions [33]. 
 
The most widely used hydroxyapatite is porous sintered because it can be easily 
invaded by osteoblasts but, due to the fragility of this component, its application 
focuses on the coating of metals or in composite materials as a filler in in plastics, 
glasses and ceramics [34]. 
One of the main characteristics of this biomaterial is the calcium-phosphorus 
molar ratio since the lower the ratio, the higher the acidity and solubility of the 
samples, as well as being a factor related to the mechanical properties of the 
material. The pure HAp phase has a Ca / P molar ratio of 1.67 [35]. 
An important characteristic of hydroxyapatite is its stability when compared to 
other calcium phosphates. Thermodynamically, hydroxyapatite is the most stable 
calcium phosphate compound under physiological conditions of temperature, pH 
and composition of the body fluids. 
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One of the disadvantages of this biomaterial is that it does not inhibit the formation 
of bacteria, presenting a low antimicrobial activity. 
 
A material is considered bioactive if it has a positive interaction with or effect on 
any cell tissue in the human body. Bioactivity is often meant as the formation of 
calcium phosphate deposits on the surface of objects placed in simulated body 
fluid (SBF). The presence of silanol groups and the textural properties of the 
bioactive material, such as porosity and pore volume, seem to play an important 
role in the formation a HAp layer during the immersion in SBF. 
 
As it is extensively explained in Paragraph 3.3, SBF is defined as an acellular, 
protein-free solution with ion concentrations approximately equal to those of 
human blood plasma. The nucleating capacity of a biomaterial can be observed 
by immersing it in SBF. It has been suggested that the nucleation of 
calcium/phosphates mimics the initial mineralization of bone on the implant 
surface. So, as HAp is a material belonging to calcium phosphates ceramics, its 
precipitation is symbol of bioactive behaviour. 
 
The present work aims to study the capacity of porous ZnO thin films precipitation 
of apatite layers by soaking them with SBF solution.  
 
2.5	Rhodamine-β	
	
Rhodamine-β is a chemical compound and a dye. It is often used as a tracer dye 
within water to determine the rate and direction of flow and transport. Rhodamine-
β dyes fluoresce and can thus be detected easily and inexpensively with 
instruments called fluorimeters. Rhodamine-β dyes are used extensively in 
biotechnology applications such as fluorescence microscopy, flow cytometry and 
fluorescence correlation spectroscopy. 
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In this thesis work Rhodamine-β has been used as a dye molecule for studying 
the capacity of porous ZnO thin films in uptaking and releasing molecules. 
 
	
Figure	4:	Rhodamine-β	chemical	structure	
	
	
	
Figure	5:	Sample	soaked	in	Rhodamine-B	for	the	uptake	experiment	
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Chapter	3.	Materials	and	methods	
	
In this chapter the methods for obtaining ZnO samples and the GO coating are 
described, as well as, the composition of SBF solution and the medium for cell 
culture. There is also an explication of all the characterization setups used and 
the uptake/release experiment done using Rhodamine-B as a tracer dye. 
	
3.1	Synthesis	of	porous	zinc	oxide	structures	by	RF	sputtering	
	
Concerning the preparation of ZnO samples, this was carried out by a 
combination of both physical vapour deposition method, named sputtering, and 
a final thermal treatment. The preparation of the samples by sputtering is carried 
out with a deposition system available at the DISAT, which uses a RF magnetron 
sputtering monotarget system. The deposition process takes place in a cylindrical 
stainless steel chamber, equipped with a single 4” circular cathode on which the  
target is clamped, facing downwards. Substrates are placed in the lower part of 
the reactor, facing upwards toward the target. These technical features guarantee 
the deposition of uniform and homogeneous coatings on the substrate area. 
 
 
 Figure	6:	Deposition	system 
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A RF signal generator, operating at a working frequency of 13.56 MHz, and a 
matching network, needed to adjust the reflected power down to zero, are 
respectively used to supply and maximize the signal power provided to the 
cathode. Sputtering deposition of materials requires suitable vacuum conditions 
before starting the deposition, granting an environment clean from 
contaminations and from residues such as oxygen and moisture. In our case, 
these are obtained by a two-stage pumping system, made by a rotary and a turbo 
molecular pumps connected in series, allowing to reach pressures as low as 10-
7 Torr [6]. 
 
The properties of sputtered ZnO thin films are known to depend on deposition 
parameters such as RF power, pressure, substrate temperature and gas 
atmosphere.  
 
So, in this work, ZnO thin films were deposited by RF sputtering on Si (1 0 0) 
substrates. First, Si substrate was diced into 1 cm x 1 cm pieces. Secondly, those 
substrates were washed in acetone and ethanol. For each solvent the samples 
were washed in 50 ml of the corresponding solvent in ultrasound bath for 10 min, 
then washed with clean solvent and finally dried under nitrogen flow. Thirdly, the 
deposition process takes place, using the parameters mentioned in Table 1. The 
main reason of using these parameters is that by using them, the obtainment of 
particular nanoporous structure of ZnO thin films was allowed. Finally, a thermal 
oxidation was done at 380ºC during 120 min performed in ambient air using a 
muffle furnace in order to oxidize the Zn layer and to obtain the conversion of the 
Zn film into ZnO nanostructured layers. 
 
 
Target	 Base	Vacuum	
[Torr]	
T	[ºC]	 Ar	flow	
[sccm]	
Pressure	
[mTorr]	
RF	power	
[W]	
Deposition	
time	[min]	
Zn	 1,7x10-7	 21	 10	 5	 30	 240	
Table	1:	Deposition	process	parameters	
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3.2	Synthesis	and	deposition	of	graphene	oxide	flakes	on	porous	ZnO	structures	
by	drop-casting	method	
	
The coating of GO flakes has been fabricated by drop casting method. GO 
dispersion in water with different concentrations of 0.1 mg/mL, 0.5 mg/mL, and 1 
mg/mL was obtained using a modification of the Hummers method [36]. The 
average lateral size of the GO sheets was on the order of a few to few tenths of 
micrometers. For each concentration, a droplet of the GO solution with a fixed 
volume of 50 μL was drop-casted on the surface of each ZnO sample. Then, each 
sample was air-dried overnight, with the twofold aim of promoting water 
evaporation and adsorption of the GO flakes to the ZnO surface, hence forming 
a continuous GO layer. 
 
At the beginning the preparation of three samples coated with different GO 
concentrations (0.1, 0.5 and 1 mg/ml respectively) was done but, from FESEM 
analyses we decided to use the 0.5 mg/ml sample since showed a better uniform 
and homogeneous coverage of the ZnO surface. 
 
 
Figure	7:	Zn	samples	after	sputtering	
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For the 0.5 mg/mL GO solution, drop-casting was performed on six ZnO samples, 
which were then soaked in SBF. The GO-coated ZnO samples were collected 
from the SBF solution after 5h, 1 day, 3 days, 1 week, 2 weeks and 3 weeks. 
	
3.3	Bioactivity	and	biodegradation	assays	using	Simulated	Body	Fluid	and	
medium	for	cells	culture	(eMEM)	
	
Simulated	body	fluid	(SBF)	
	
Simulated body fluid (SBF) is a solution which has ions concentrations nearly 
equal to those of human blood plasma and is buffered at pH 7.4 at 36.5 ºC. 
	
	
Table	2:	Comparison	between	ion	concentration	in	SBF	and	in	human	blood	plasma	
 
For obtaining this solution one litre polyethylene bottle was filled with 500ml of 
ion exchanged and distilled water and a magnetic stirrer into it for dissolving the 
reagents added in the following order: 
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Table	3:	Reagents	for	preparing	SBF	solution	
	
Once all the reagents were dissolved, the temperature was adjusted at 36.5ºC 
with a water bath and adjusted the pH at 7.40 by stirring the solution and titrating 
1N·HCl solution. After that, a transfer of the solution to a volumetric glass flask 
and an adjustment of the total volume of the solution to one litre by adding ion 
exchanged and distilled water and shaking the flask at 20ºC, were done. [37] 
Finally, the bottle was stored in the refrigerator at 5ºC and used within one month 
from the production.  
 
Each of the samples were placed in different plastic flasks with SBF into the 
orbital shaker (for simulating the body fluids movement) at 37ºC, during the time 
corresponding each sample had to be. Each time a sample was removed from 
the SBF solution, it was cleaned with distilled water and dried at room 
temperature.  
 
The refresh of the solution was done to some samples every 2 days, which means 
that there was a change of the SBF solution. It was done in order to study the 
HAp precipitation on the sample surface. In contrast, to study the biodegradation 
of the samples there were others without refresh thus, it was easier to investigate 
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the release of ions from the sample to the solution. The bioactivity analyses were 
done according to the Kokubo Test [38]. 
 
The orbital shaker used was ExcellaTM E24/ Temperature-Controlled Benchtop 
Shakers and the parameters of shaking were a continuous shaking at 160 rpm 
with a temperature of 37ºC. 
 
 
	
Figure	8:	Orbital	Shaker	
 
 
	 Cell	culture	medium	(eMEM)	
	
Cell culture medium is a solution designed to support the growth of cells under 
controlled conditions. Even cell culture conditions can vary for each cell type, 
artificial environments consist of a suitable vessel with substrate or medium that 
supplies the essential nutrients and regulates the physico-chemical environment. 
The eMEM used in this thesis work have been done by following M4655 Sigma-
Aldrich instructions described in Table 4. 
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Table	4:	Quantities	of	the	components	needed	for	obtaining	M4655	eMEM	
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To this eMEM, there has been added 10% of Fetal Bovine Serum (FBS) with the 
following composition (Table 5). 
	
	
Table	5:	Composition	of	FBS	
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Also, with the addition of penicillin-streptomycin at 1%. 
 
	
Table	6:	Composition	of	penicillin-streptomycin	
	
3.4	Uptake	and	release	Rhodamine-β dye	molecule	on	porous	ZnO	structures	for	
drug	delivery	applications	experiment	preparation	
	
As it is mentioned above, Rhodamine-B is used in this work thesis as a dye 
molecule for studying the uptake and release of this solution from porous ZnO 
thin films. 
 
The followed methodology begins with a measurement of UV absorbance of 
Rhodamine-β each time the experiment have been done for observing the 
calibration curvature of the solution at that point. Rhodamine-β photodegradation 
with UV has to be taken in account when doing this experiment as every time the 
solution was exposed UV light its properties could vary. 
 
Then, for observing the uptake of Rhodamine-β dye molecule on porous ZnO thin 
films 20ml of Rhodamine-β were put inside a flask with a magnetic stirrer and the 
sample and leaved it stirring at 600 rpm. As this solution is easily degraded by 
UV light, covering the flask with aluminium paper was essential. After 1, 2, 3, 4, 
5 and 24 hours we collected 100µl of the solution and placed it in the microplate. 
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100µl of Rhodamine-β and 100µl of water were also collected before the 
experiment. 
 
	
Figure	9:	Uptake	experiment	with	Rhodamine-B	solution	covered	with	aluminium	paper	stirring	at	600	
rpm	
	
For the release experiment, a plastic tube filled with SBF solution and a magnetic 
stirrer was put it into an experimental setup stirring at 150 rpm, with constant 
temperature of 37ºC. After 30 min (time estimated for the solution to get the 
necessary conditions) the sample was placed inside. To evaluate the amount of 
Rhodamine-β released from the porous ZnO sample, 100µl of the solution at 
different time points: after 5, 15, 30 minutes, 1, 2, 4 and 6 hours and then after 1, 
2 and 3 days, were collected and put  into the microplate. As in the uptake 
experiment, 100µl of SBF solution before the experiment and 100µl of water were 
also collected. 
 
By using the microplate reader, the amount of Rhodamine-β that have been 
uptaken from the sample and the amount of Rhodamine-β that have been 
released to the SBF solution were obtained. 
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Figure	10:	96-well	microplate	used	for	estimating	the	amount	of	Rhodamine-B	uptaken	and	released	by	
the	ZnO	porous	samples	
	
3.5	Physico-chemical	characterization	setups	
	
	 3.5.1	X-Ray	Diffraction	(XRD)	
	
X-ray diffraction (XRD) is a method useful to determine the crystallinity of a 
compound and it is primarily used for: 
• Identification of crystalline material 
• Identification of different polymorphic forms 
• Distinguishing between amorphous and crystalline material 
• Quantification of the percent crystallinity of a sample 
 
XRD analysis is based on constructive interference of monochromatic X-rays and 
a crystalline sample: The X-rays are generated by a cathode ray tube, filtered to 
produce monochromatic radiation, collimated to be spatially localized, and then 
directed toward the sample. The interaction of the incident rays with the sample 
produces constructive interference (and a diffracted ray) when conditions satisfy 
Bragg’s Law (nλ=2d sin θ). This law relates the wavelength of electromagnetic 
radiation to the diffraction angle and the lattice spacing in a crystalline sample. 
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The characteristic x-ray diffraction pattern generated in a typical XRD analysis 
provides a unique “fingerprint” of the crystals present in the sample. When 
properly interpreted, by comparison with standard reference patterns and 
measurements, this fingerprint allows identification of the crystalline form. 
 
The result from an XRD analysis is a diffractogram showing the intensity of the 
diffracted beam as a function of the diffraction angles (2θ).   
 
With these measurements there was the expectancy to see clearly the peaks 
corresponding to ZnO crystalline structure and the HAp peaks if it is precipitated. 
 
The instrument used is shown in Figure 11, and consists of a PANalytical X’Pert³ 
Powder diffractometer of Dipartimento di Scienza Applicata e Tecnologia (DISAT) 
of Politecnico di Torino. The parameters used were an intensity of 30mA and a 
tension of 40kV. 
 
	
Figure	11:	PANalytical	X’Pert³	Powder	
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	 3.5.2	Field-Emission	Scanning	Electron	Microscopy	(FESEM)	
	
Field Emission Scanning Electron Microscopy (FESEM) reveals detailed 
information about the morphology and the composition of materials at 
magnifications 12x to 900,000x, with virtually unlimited depth of field.   
 
 
It’s principle of operation is based on a field-emission cathode in the electron gun 
of a scanning electron microscope that provides narrower probing beams at low 
as well as high electron energy, resulting in both improved spatial resolution and 
minimized sample charging and damage.   
 
FESEM analyses were performed in order to see the morphology of the sample 
focusing on calcium and phosphorous structures and its coverage on the surface 
of the sample. 
The instrument used was SUPRA™ 40 (ZEISS) that has been developed as an 
extremely versatile FESEM capable of delivering high quality imaging solutions 
for the many demanding applications in the field of nanotechnology. The 
parameters found in Table 7 are the characteristics of this instrument. 
 
Nominal resolution at 
10kV and WD=2mm 
Acceleration 
voltage 
Probe 
current 
Magnification Working 
distance 
1.5nm 0.1 – 30kV 4pA – 10nA 12 – 900,000X 1 – 50mm 
Table	7:	SUPRA™	40	(ZEISS)	characteristics	
 
The sample holder can host nine stubs. Each stub can contain samples of about 
1 cm2. 
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Figure	12:	SUPRA™	40	(ZEISS)	
	
3.5.3	Attenuated	Total	Reflection	(ATR)	–	IR	spectroscopy	
	
Mid-Infrared (IR) spectroscopy is an extremely reliable and well recognized 
fingerprinting method. Most substances show a characteristic spectrum that can 
be directly recognized. ATR-IR spectroscopy enables measuring all types of 
samples: solids, liquids and gases. 
 
The ATR principle is based on the ATR crystal that comprises an IR transparent 
material with a high refractive index and polished surfaces. 
 
	
Figure	13:	ATR	principle	
	
As shown in Figure 13, the infrared beam enters the ATR crystal at an angle of 
typically 45° and is totally reflected at the crystal to sample interface. Because of 
its wave-like properties, the light is not reflected directly by the boundary surface 
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but by a virtual layer within the optically less dense sample. The fraction of light 
reaching into the sample is known as evanescent wave. Its penetration depth 
depends on the wavelength, the refractive indices of the ATR crystal and the 
sample, and the angle of the entering light beam. It is typically on the order of a 
few microns (ca. 0.5 - 3 μm). In the spectral regions where the sample absorbs 
energy, the evanescent wave is attenuated. After one or several internal 
reflections, the IR beam exits the ATR crystal and is directed to the IR-detector. 
	
ATR-IR measurements were done in order to study the substances of which our 
samples are composed and the different impact they cause. ATR-IR spectrum 
were collected in the range of 4000-400 cm-1, at 2 cm-1 resolution. 64 scans were 
accumulated for each spectrum on a Nicolet 5700 FTIR spectrometer 
(Thermofisher) equipped with a room temperature working deuterated triglycine 
sulphate (DTGS) detector and a diamond crystal accessory. In Figure 14 there is 
an example of ATR-IR spectrum instrument.  
 
	
Figure	14:	ATR-IR	spectrometer	
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	 3.5.4	Energy-Dispersive	X-Ray	Spectroscopy	(EDS)	maps	
	
Energy-dispersive X-ray spectroscopy (EDS) is an analytical technique used for 
the elemental analysis and chemical characterization of a sample. It relies on an 
interaction of incident primary electron and the consequent emission of X-ray 
from the sample. Its characterization capabilities are due to the principle that each 
element has a unique atomic structure allowing a unique set of peaks on its 
electromagnetic emission spectrum. 
 
The number and energy of the X-rays emitted from a specimen can be measured 
by an energy-dispersive spectrometer. As the energies of the X-rays are 
characteristic of the difference in energy between the two shells and the atomic 
structure of the emitting element, EDS allows the elemental composition of the 
specimen to be measured. 
 
Four primary components of the EDS setup are: 
• the excitation source (electron beam or x-ray beam) 
• the X-ray detector 
• the pulse processor 
• the analyser 
 
In this thesis, EDS maps have been carried out with the twofold aim of estimating 
the chemical composition of the samples and the distribution of the elements on 
the samples surface. The setup used in this thesis work consisted of a desktop 
SEM Phenom XL equipped with EDS analyser. Each EDS map was acquired on 
a 1000X SEM image, with the parameters described in Table 8. 
 
Map resolution Acquisition time per pixel Number of scans 
128 pixel 20ms 1 
Table	8:	EDS	maps	parametres	
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3.5.5	Inductively	Coupled	Plasma	(ICP)	mass	spectrometry	
	
ICP-MS is an analytical technique used for elemental determinations that has 
many advantages such as atomic absorption, optical emission spectrometry, high 
throughput and detection limits for most elements equal to or better than other 
standard methods for element identification.  
 
	
Figure	15:	ICP	Torch	showing	the	fate	of	the	sample	
	
An ICP-MS combines a high-temperature ICP (Inductively Coupled Plasma) 
source with a mass spectrometer. The ICP source converts the atoms of the 
elements in the sample into ions. These ions are then separated and detected by 
the mass spectrometer. 
 
The sample is typically introduced into the ICP plasma as an aerosol, either by 
aspirating a liquid or dissolved solid sample into a nebulizer or using a laser to 
directly convert solid samples into an aerosol. Once the sample aerosol is 
introduced into the ICP torch, it is completely dissolved and the elements in the 
aerosol are converted first into gaseous atoms and then ionized towards the end 
of the plasma. 
 
Once the elements in the sample are converted into ions, they are then brought 
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into the mass spectrometer via the interface cones. The interface region in the 
ICP-MS transmits the ions traveling in the argon sample stream at atmospheric 
pressure into the low pressure region of the mass spectrometer. This is done 
through the intermediate vacuum region created by the two interface cones, the 
sampler and the skimmer. 
 
 
	
Figure	16:	Interface	region	of	an	ICP-MS	
	
The ions from the ICP source are then focused by the electrostatic lenses in the 
system.  
 
Once the ions enter the mass spectrometer, they are separated by their mass-to-
charge ratio. The most commonly used type of mass spectrometer is the 
quadrupole mass filter. 
 
	
Figure	17:	Schematic	of	quadrupole	mass	filter	
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The ability to filter ions on their mass-to-charge ratio allows ICP-MS to supply 
isotopic information, since different isotopes of the same element have different 
masses. [39]  
 
In this thesis work an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
(mod. 7500cc, AGILENT TECHNOLOGIES, Milan, Italy) was used, with the aim 
of finding how changed are the ions of the solution after the samples of porous 
ZnO and ZnO coated with GO have been soaked there. 
 
3.5.6	Microplate	reader	
	
Microplate readers are instruments used to detect biological, chemical or physical 
events of samples in microtiter plates. They are widely used in research, drug 
discovery, bioassay validation, quality control and manufacturing processes in 
the pharmaceutical and biotechnological industry and academic organizations.  
 
The most common microplate format used in academic research laboratories or 
clinical diagnostic laboratories is 96-well (8 by 12 matrix) with a typical reaction 
volume between 100 and 200 µL per well. Common detection modes for 
microplate assays are absorbance, fluorescence intensity, luminescence, time-
resolved fluorescence, and fluorescence polarization. 
 
	
Figure	18:Microplate	Reader	
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The one used in this thesis work was a Multiskan™ GO Microplate 
Spectrophotometer from Thermo Fisher Scientific, that analyses the most 
common microplate format 96-well (8 by 12 matrix) detecting the UV absorption 
of the specimens introduced, as reported in Figure 10 with a typical reaction 
volume of 100 µL. 
 
3.5.7	Fluorescence	Microscopy	
	
Fluorescence microscopy is a technique for acquiring microscopic images of 
samples (often biological materials) using fluorescence within the sample, which 
is usually excited with a sharply focused diffraction-limited laser beam.  
 
The focus of the laser beam is raster scanned through the simple, and the 
fluorescent light excited in the sample is collected with some optics and monitored 
with a photodetector. Residual laser light can be eliminated with an optical filter 
before the detector.  
 
The fluorescence microscope is usually operated with a computer (a PC or a 
laptop), which controls the scan, records the fluorescence intensities, and finally 
generates, processes and stores the obtained images. 
 
The fluorescence can originate from molecules which occur naturally in the 
sample, or from dye molecules which are introduced during sample preparation.  
 
In the simplest form of fluorescence microscopy, the laser is operated 
continuously, and its wavelength is chosen to be in an absorbing spectral region 
of the fluorescent molecules, which can therefore be excited with single-photon 
absorption. 
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As mentioned above, fluorescence microscopy is mostly used for biological 
samples. It is currently investigated in which form fluorescence microscopy can 
be used e.g. for the detection of cancer. It is also useful for imaging living cells 
[40].  
 
	
Figure	19:	Basic	Optical	Filtering	Arrangement	for	Fluorescence	Microscopy		
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Chapter	4.	Results	and	discussion	
	
For studying the interaction of porous ZnO thin films with simulated body fluid 
(SBF) and medium for cells culture (eMEM), an investigation of the samples 
soaked for different periods of time was done in terms of their morphology, crystal 
structure and chemical composition. The above mentioned characteristics were 
investigated by means of Field-Emission Scanning Electron Microscopy 
(FESEM) measurements, x-Ray Diffraction (XRD), Attenuated Total Reflection 
(ATR) and Energy Dispersive X-ray Spectroscopy (EDS), respectively. 
 
For investigating the possible drug delivery applications, the capacity of porous 
ZnO samples to uptake and release Rhodamine-B was studied. 
 
The results of this thesis work are structured in 4 sections, the first concerning 
the in-vitro evaluation of bioactivity and biodegradation properties of porous ZnO 
samples soaked in SBF, the second concerning the same evaluation for the ZnO 
samples coated with GO, the third concerning the in-vitro evaluation of cell culture 
formation on porous ZnO samples soaked in eMEM, and finally a fourth section 
in which there are reported the results concerning the ability of ZnO samples to 
uptake and release Rhodamine-B dye molecule. 
 
For the first two sections, the analyses mentioned above were done on 12 
samples of ZnO and to 6 samples of ZnO coated with GO soaked in SBF solution. 
In the third section, the analyses were done on 5 samples soaked in medium for 
cells culture.  
 
Concerning the ZnO samples soaked in SBF solution, there are 7 samples 
without SBF refreshing, i.e., the SBF solution was not changed during the 
experiments and 5 samples with refresh, meaning that change of the SBF 
solution with a fresh one was performed every 2 days. 
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Figure	20:	Diagram	resuming	sample’s	tests	and	time	steps,	where	h:	hours,	D:	days,	W:	weeks,	M:	
month	
	
The experiment performed in SBF was done until 2M soaking time because the 
result desired are appreciable after long periods of time while, in the experiment 
performed in eMEM, the typical time needed to well appreciate cell culture 
structures formation is 3D. 
 
	
4.1	In-vitro	evaluation	of	bioactivity	and	biodegradation	properties	of	porous	ZnO	
structures	soaked	in	SBF	
	
Bioactivity and biodegradation properties were studied with the above mentioned 
characterization setups. The results are divided into sections, according to the 
physicochemical characterization method.  
 
4.1.1	Attenuated	Total	Reflection	(ATR)	
	
ATR is an effective method to reveal the composition of specific compounds, 
represented by the presence of IR absorbance bands for each specific chemical 
group. In Figure 21 and Figure 22, are shown the different ATR spectra obtained 
from the analyses of all the ZnO samples with refresh and without refresh, 
respectively.  
 
 
SBF
ZnO 5h 1D
3D 1W 2W 1M 2M	
3D	ref 1W	ref 2W	ref 1M	ref 2M	ref
ZnO/GO 5h 1D 3D 1W 2W 3W
eMEM ZnO 1h 5h 1D 2D 3D
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When soaking porous ZnO samples in SBF solution there is an appreciation of 
the different phosphates bands, one positioned between 969 and 1190 cm-1 and 
corresponding to v3 mode, a second one at 960 cm-1 corresponding to v1 mode, 
and another between 550 and 680 cm-1 corresponding to v4 mode. The presence 
of OH groups is also noticed between those two bands. The amide I band is also 
present with the corresponding band, located in the range 1600 – 1700 cm-1 and 
with a maximum at 1650 cm-1 [41]. 
 
 
Figure	21:	ATR	spectra	of	ZnO	samples	soaked	in	SBF	with	refresh	
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Figure	22:	ATR	spectra	of	ZnO	samples	soaked	in	SBF	without	refresh	
	
	
	
4.1.2	Energy-Dispersive	X-Ray	Spectroscopy	(EDS)	
	
The EDS technique has been used for obtaining a map of the chemical 
composition of the samples.  
 
In Figure 23 and Figure 24 there is the evolution of the EDS maps among the 
soaking time in SBF with refreshing and without refreshing the SBF solution, 
respectively. After soaking the sample for 5h, a fast precipitation of P from SBF 
solution is obtained. By increasing the soaking time, i.e., after 1D, Ca precipitation 
also started to appear (purple pixels). Also, in the last EDS map, corresponding 
to the 2M with refresh sample, we can find a little contribution of chlorine. 
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Figure 25 and Figure 26, show the evolution of Ca and P content versus the 
soaking time. It is well visible that both Ca and P concentrations increases with 
time (both with and without refreshing the SBF solution). Moreover, the Ca/P 
stoichiometry ratio slightly increases by increasing the soaking time.  
 
 
(a)	 (b)	 (c)	 (d)	
(e)	 (f)	 (g)	
Figure	23:	EDS	map	of	the	ZnO	samples	soaked	in	SBF	without	refresh	for:	(a)	5h,	(b)	1D,	(c)	3D,	(d)	1W,	(e)	2W,	(f)	1M,	(g)	2M 
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Figure	25:	Evolution	of	Ca	and	P	versus	the	soaking	time	without	refreshing	the	SBF	solution	
	
0,00
1,00
2,00
3,00
4,00
5,00
6,00
5h 1D 3D 1W 2W 1M 2M
Without	refresh
Ca P
(a)	 (b)	 (c)	 (d)	
(e)	 (f)	 (g)	
Figure	24:	EDS	map	of	the	ZnO	samples	soaked	in	SBF	with	refresh	for:	(a)	5h,	(b)	1D,	(c)	3D,	(d)	1W,	(e)	2W,	(f)	1M,	(g)	2M 
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Figure	26:	Evolution	of	Ca	and	P	versus	the	soaking	time	when	refreshing	the	SBF	solution	
	
 
With the data obtained, we found that, by increasing the soaking time in the SBF 
solution, the amount of Calcium (Ca) and Phosphorous (P) increases 
accordingly. 
 
If we only contemplate those analyses, we can not affirm that hydroxyapatite is 
precipitated on the surface of the samples, since Ca/P stoichiometry ratio of 1.67 
should be obtained. But, as Ca precipitation is observed, it is likely HAp to be 
formed. Moreover, it is mandatory to take into account that part of the P is 
chemically bound to Zn, and participating in the formation of zinc phosphates. 
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4.1.3	Field-Emission	Scanning	Electron	Microscopy	(FESEM)	
	
The morphology of the investigated samples was investigated by FESEM 
analyses. 
 
The following images show the evolution of the samples at increasing time in 
SBF. Figure 27 and Figure 28 show the FESEM images for the samples soaked 
in SBF for 5 hours and 1 day, respectively, acquired with different magnifications. 
The following three (Figure 29, Figure 30 and Figure 31) correspond to the 
samples soaked in SBF for 3 days, 1 week and 2 weeks, respectively. When 
applicable, the left panel of the FESEM image refers to the ZnO sample soaked 
in SBF without refresh, while the right part shows the ZnO sample soaked with 
refresh of SBF, for the same soaking time. 
	
	
Figure	27:	FESEM	image	of	ZnO	soaked	in	SBF	for	5h.	25,00	KX	left,	50,00	KX	middle,	100,00	KX	right	
	
Figure	28:	FESEM	image	of	ZnO	soaked	in	SBF	for	1D.	25,00	KX	left,	50,00	KX	middle,	100,00	KX	right	
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Figure	29:	FESEM	image	of	ZnO	soaked	in	SBF	for	3D.	50,00	KX	without	refresh	left,	50,00	KX	with	refresh	
right	
	
Figure	30:	FESEM	image	of	ZnO	soaked	in	SBF	for	1W.	50,00	KX	without	refresh	left,	50,00	KX	with	refresh	
right	
	
Figure	31:	FESEM	image	of	ZnO	soaked	in	SBF	for	2W.	50,00	KX	without	refresh	left,	50,00	KX	with	
refresh	right	
	
Finally,	in	Figure	32	there	is	a	comparison	between	the	sample	after	1M	and	the	sample	
after	2M	(both	samples	were	with	refreshing	the	SBF	solution).	
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Figure	32:	Comparison	between	1M	sample	(left)	and	2M	sample	(right)	
	
The results of the ZnO samples soaked in SBF solution show that a phase of 
calcium phosphate (biological apatite) can grow efficiently over a porous ZnO thin 
film, by incubating it in a solution with ionic composition similar to that of blood 
plasma. Calcium phosphate nucleation started from the first day. As the 
immersion time increases calcium phosphates cover the entire surface. In the 
samples without refreshing, the appearance of calcium phosphates was 
observed too. No appreciable differences in the dimension of CaP precipitates 
was generally observed by refreshing the SBF solution.  
	
	
4.1.4	X-Ray	Diffraction	(XRD)	
	
XRD was selected as the most suitable method to study the crystal structure of 
the samples. 
	
XRD analyses have been first carried out on the porous ZnO samples soaked in 
SBF without refreshing the solution. The different ZnO samples were collected 
from the SBF solution after 5h, 1 day (1D), 3 days (3D), 1 week (1W), 2 weeks 
(2W),1 month (1M) and 2 months (2M), respectively. Finally, the XRD patterns of 
the 5 ZnO samples soaked in SBF by refreshing the solution every 2 days were 
also investigated (3D-refr, 1W-refr, 2W-refr, 1M-refr, 2M-refr). 
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Independently of refreshing the SBF solution, the XRD patterns do not show 
significant differences in the crystal structure of the different ZnO samples soaked 
in SBF up to 1 month. Until this time point, all of them are characterized by 
relatively strong ZnO (100), ZnO (002) and ZnO (101) diffraction peaks 
characteristics of the hexagonal wurtzite ZnO structure. Additional peaks 
corresponding to the ZnO (102) and ZnO (110) planes have been detected as 
well, even though with a lower intensity.  
	
The XRD peak position detected for all the porous ZnO samples soaked in SBF 
are reported in Table 9. 
	
Figure	33:	XRD	pattern	of	the	porous	ZnO	samples	soaked	in	SBF 
 2θ position 
Sample ZnO (100) ZnO (002) ZnO (101) ZnO (102) ZnO (110) HAp(200) HAp(203) 
5h 32.20º 34.85º 36.67º 47.95º 56.99º - - 
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Table	9:	XRD	peaks	position	of	ZnO	samples	soaked	in	SBF 
 
The crystal structure remains exactly the same during the first month. All the XRD 
peaks were indexed and well matched with the standard hexagonal structure of 
ZnO. In some cases, a diffraction contribution always positioned at 33º appeared 
and was due to diffraction coming from the silicon (Si) substrate. No other 
characteristic peaks related to impurities and any intermediate materials were 
observed, which further confirms that the diffractograms reflects a pure ZnO 
structure  [42]. 
	
Finally, for the sample soaked in SBF for 2 months, there is an appreciation of 2 
additional XRD peaks, one at 21,76º, and one at 45,3º, corresponding to (200) 
and (203) planes of HAp crystal structure. 
 
This conclusion was reached by comparing the typical pattern of HAp (Figure 34) 
with the pattern of sample 2M. It is evident that all of them are related to the 
beginning of precipitation of HAp on the surface of the sample.  
1D 32.20º 34.84º 36.68º 48.00º 56.98º - - 
3D 31.62º 34.27º 36.08º 47.42º 56.51º - - 
3D ref 32.17º 34.77º 36.63º 47.92º 56.96º - - 
1W 32.27º 34.90º 36.47º 48.00º 57.09º - - 
1W ref 32.25º 34.85º 36.71º 47.98º 57.00º - - 
2W 31.96º 34.58º 36.39º 47.69º 56.75º - - 
2W ref 32.25º 34.85º 36.61º 48.00º 57.00º - - 
1M ref 32.28º 34.93º 36.72º 48.03º 57.04º - - 
2M 31.85º 34.55º 36.36º 47.68º 56,66º 21.76º 45.3º 
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Figure	34:	Typical	pattern	of	HAp	
	
	
4.1.5	Inductively	Coupled	Plasma	(ICP)	mass	spectrometry	
 
In order to study the biodegradation of porous ZnO when soaked in the media 
mentioned, ICP analyses have been performed on the solutions after removing 
the samples to evaluate the concentration of Ca2+, PO4-- and Zn2+ ions versus the 
soaking time. The aim of this analysis is twofold: (1) to evaluate the precipitation 
of P and Ca from the SBF solution to the ZnO sample, and (2) to get information 
about the kinetics of degradation, by evaluating the amount of Zn2+ ions released 
from the sample to the SBF solution. 
	
Since the EDS maps and the atomic composition of the samples obtained for the 
samples showed an increase of P and Ca amounts versus the soaking time, ICP 
analyses of the corresponding SBF solution were expected to show a decrease 
of these elements. The P decreases to zero mainly after the first month soaking 
time, while Ca slightly increases and decreases until finally reducing its amount 
during the second month.  
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This fact is due to the bioactivity of the sample when soaking it in the SBF 
solution: the sample surface acts as nucleation sites for the HAp precipitation, 
thus recruiting Ca and P from the SBF. 
 
	
Figure	35:	ICP	results	when	evaluating	the	evolution	of	Ca	and	P	of	the	SBF	solution	among	the	time		
	
On the other hand, Zn2+ concentration increases due to the biodegradation of the 
samples. 
 
	
Figure	36:	ICP	results	when	evaluating	the	evolution	of	Zn	of	the	SBF	solution	among	the	time	
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4.2	In-vitro	evaluation	of	bioactivity	and	biodegradation	properties	of	porous	
ZnO/GO	structures	soaked	in	SBF	solution	
	
Hypothesizing that a GO coating could improve the formation of apatite layer, the 
same physico-chemical studies were carried out on 6 porous ZnO samples 
coated with GO. 
	
4.2.1	Attenuated	Total	Reflection	(ATR)	
	
Concerning ATR analyses, the results are very similar to the ones obtained by 
soaking the porous ZnO samples into SBF solution (reported at 4.1.1).  
 
The different phosphates bands can be observed, one positioned between 960 
and 1190 cm-1 corresponding to v3 mode, a second one at 940 cm-1 corresponding 
to v1 mode and another between 540 and 660 cm-1 corresponding to v4 mode. 
The presence of OH groups is also noticed between these two bands. The amide 
I band is also present with the corresponding band, located in the range 1600 – 
1700 cm-1 and with a maximum at 1640 cm-1. 
 
	
Figure	37:	ATR	spectra	of	ZnO/GO	samples	soaked	in	SB	
		
	
52	
4.2.2	Energy-Dispersive	X-Ray	Spectroscopy	(EDS)	
	
Regarding the chemical composition studied with EDS maps, also in this case an 
increase of Ca and P amounts is obtained while increasing the soaking time. 
 
By comparing those results with the ones obtained with porous ZnO samples 
soaked in SBF, it can be observed that the precipitation of Ca and P onto the 
ZnO/GO surface is more quick.  Moreover, the corresponding amount obtained 
for the same soaking time is higher when the sample is coated with GO, due to 
the more pronounced bioactivity behaviour. 
 
As it was mentioned in Paragraph 4.1.2, those analyses cannot affirm that there 
is forming hydroxyapatite as, for its formation, a Ca/P stoichiometry ratio equal to 
1.67 is required.  
 
In Figure 38 it is shown the evolution of Ca (purple) and P (yellow) amounts 
versus time, showing the increase of the Ca/P stoichiometry, reaching a value of 
0.7 after soaking for 3W. In Figure 39 the evolution of the EDS maps along the 
time. 
 
Figure	38:	Evolution	of	Ca	and	P	versus	the	soaking	time	
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Figure	39:	EDS	map	of	the	ZnO	samples	coated	with	GO	and	soaked	in	SBF	for:	(a)	5h,	(b)	1D,	(c)	3D,	(d)	
1W,	(e)	2W,	(f)	3W	
	
4.2.3	Field-Emission	Scanning	Electron	Microscopy	(FESEM)	
	
Images about the evolution of the surface morphology of the samples were 
obtained using FESEM characterization. In order to obtain biological results, the 
morphology of ZnO coated with GO was studied in three different concentrations: 
0.1 mg / ml, 0.5 mg / ml and 1 mg / ml. With all the data obtained it was decided 
to use the concentration of 0.5mg / ml to proceed with the experiments, 
corresponding to the optimal coating from our point of view, therefore by coating 
ZnO with GO at this concentration it is expected that the bioactivity for tissue 
engineering would be promoted. 
 
Figure	40:	FESEM	analyses	of	ZnO	coated	with	GO	at	0.1mg/ml	(left),	0.5mg/ml	(middle)	and	1mg/ml(right) 
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The formation of calcium phosphates on the surface of the sample is easy to be 
identified in the following images. The sample soaked for only 5h shows 
formations of less than 200nm of diameter while, as the soaking time increases, 
the amount of calcium phosphates increases too. Finally, in Figure 46 it is 
reported a compact structure at a magnitude of 350,00KX. 
	
	
	
Figure	41:	FESEM	GO	with	SBF	5h.	50,00	KX	left,	100,00	KX	middle	and	150,00	KX	right	
	
Figure	42:	FESEM	GO	with	SBF	1D.	5,00	KX	left,	50,00	KX	right	
	
Figure	43:	FESEM	GO	with	SBF	3D.	5,00	KX	left,	50,00	KX	right	
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Figure	44:	FESEM	GO	with	SBF	1W.	5,00	KX	left,	50,00	KX	right	
	
Figure	45:	FESEM	GO	with	SBF	2W.	5,00	KX	left,	50,00	KX	right	
	
Figure	46:	FESEM	GO	with	SBF	3W.	10,00KX	left,	50,00KX	middle,	350,00KX	right	
	
	
This refers to the ZnO/GO sample soaked in SBF for 3 weeks, showing that the 
precipitation of a compact HAp layer on the ZnO/GO surface started to occur, as 
also witnessed by the XRD results below.   
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4.2.4	X-Ray	Diffraction	(XRD)	
	
Figure 47 show the XRD patterns of all the investigated ZnO/GO samples, after 
soaking in SBF up to 3W. All the detected peaks, together with the corresponding 
2θ positions and Miller indices are listed in Table 10. The obtained results are 
similar to those obtained for the porous ZnO samples soaked in SBF without the 
presence of GO. However, by adding a GO coating on the samples, the 
precipitation of HAp is more quick. This conclusion has been reached by 
comparing the XRD patterns of the ZnO/GO sample soaked in SBF for 3W and 
of the ZnO sample soaked for 1M. While the XRD pattern of the ZnO sample 
soaked for 1M only shows the diffraction peaks characteristic of wurtzite ZnO, in 
the 3W ZnO/GO sample there is an appreciation of an HAp peak, positioned at 
45.46º and ascribed to the reflection of (203) planes. 
	
	
Figure	47:	XRD	pattern	of	porous	ZnO	samples	coated	with	GO	and	soaked	in	SBF	
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Table	10:	XRD	peaks	position	of	ZnO/GO	samples	soaked	in	SBF	
	
	
4.2.5	Inductively	Coupled	Plasma	(ICP)	mass	spectrometry	
	
To study the biodegradation of ZnO samples coated with GO when immersed in 
SBF, the ICP analysis of the SBF solution after removing the sample was 
performed.  
	
Taking into account that the EDS maps and the atomic composition of the 
samples show an increase of P and Ca among the time, ICP analyses of the SBF 
solution were expected to show a decrease of this elements.  
 
Both of the elements showed a similar behaviour. During the first hours their 
concentrations decrease, assuming that they precipitate on the sample surface, 
but when reaching the first week of soaking time, their concentration increases 
again, with a final decrease during the second week, corresponding to the 
beginning of HAp precipitation.  
 
The evolution of P intensity changes much more that the one corresponding Ca. 
	
 2θ position 
Sample ZnO (100) ZnO (002) ZnO (101) ZnO (102) ZnO (110) HAp 
5h 31.88º 34.54º 36.37º 47.69º 56.73º  
1D 31.88º 34.54º 36.37º 47.67º 56.78º  
3D 31.86º 34.48º 36.35º 47.67º 56.73º  
1W 31.86º 34.48º 36.32º 47.72º 56.75º  
2W 31.83º 34.48º 36.32º 47.67º 56.73º  
3W 31.80º 34.48º 36.32º 47.62º 56.65º 45.46º 
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Figure	48:	ICP	results	when	evaluating	the	evolution	of	Ca	and	P	of	the	SBF	solution	among	the	time		
 
The evolution of Zn2+ ions versus time is strongly different from what observed 
for the samples without the GO coating; it slightly increases, especially after 
soaking the sample for 1W. Therefore, the presence of the GO coating helps in 
limiting the degradation of the underlying porous ZnO layer. 
	
	
	
	
Figure	49:	ICP	results	when	evaluating	the	evolution	of	Zn	of	the	SBF	solution	among	the	time		
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By comparing those results with the ZnO samples, and as it is demonstrated with 
the other characterization results, both, biodegradation and bioactivity, are 
noticed earlier when coating the sample with GO. 
 
4.3	In-vitro	evaluation	of	bioactivity	and	biodegradation	properties	of	porous	ZnO	
structures	soaked	in	eMEM	
	
4.3.1	Attenuated	Total	Reflection	(ATR)	
	
The samples soaked in eMEM show different ATR spectra. They are also 
characterized by the phosphates bands, however by soaking the sample into this 
medium, peaks in the region between 1400 and 1600 cm-1 were obtained, due to 
carbonate ions. These carbonate bands are assigned to surface carbonate ions, 
rather than carbonate ions in the lattice of phosphate ions.  The amide I band 
(1600 – 1700 cm-1) is also present.  
 
	
Figure	50:	ATR	spectra	of	ZnO	samples	soaked	in	eMEM	
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4.3.2	Field-Emission	Scanning	Electron	Microscopy	(FESEM)	
	
The following images show the evolution of this zinc phosphates formations 
among the time. First, after 5h, then after 1D, 2D and finally 3D, which is the 
typical time needed to well appreciate such structures formation. 
	
	
Figure	51:	FESEM	image	of	ZnO	soaked	in	eMEM	for		5h.	10,00KX	left,	50,00KX	right	
	
Figure	52:	FESEM	image	of	ZnO	soaked		in	eMEM	for	1D.	10,00KX	left,	50,00KX	middle,	150,00KX	right	
	
Figure	53:	FESEM	image	of	ZnO	soaked		in	eMEM	for	2D.	10,00KX	left,	50,00KX	middle,	150,00KX	right	
	
Figure	54:	FESEM	image	of	ZnO	soaked		in	eMEM	for	3D.	10,00KX	left,	50,00KX	middle,	150,00KX	right	
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Concerning the samples soaked in eMEM, by increasing the soaking time in 
medium for cell culture there is an appreciation of the growth of zinc phosphates 
formations.  This can be due to the lower solubility product constant of Zn3(PO4)2 
than that of Ca3(PO4)2. Therefore, in aqueous solution PO43- ions combine more 
easily with Zn2+ ions than with Ca2+. This conclusion was reached by comparing 
these samples with those soaked in SBF, and knowing that in the medium for cell 
culture there is no formation of calcium phosphates.  
 
By taking a look to the ATR-IR spectrum shown in Figure 21, Figure 22 and Figure 
50, it is easy to see that the phosphates band is similar when soaking in any of 
both solutions (eMEM and SBF). According to this fact and, since there is no 
possibility of calcium phosphates formation, it is believed that the observed 
structures are due to the formation of zinc phosphates. 
 
Figure 55 compares two representative FESEM images of the structures 
obtained by soaking the samples either in SBF or eMEM media. The first one is 
ascribed to calcium phosphates whereas the second is ascribed to zinc 
phosphates, which looks like more amorphous and compact than calcium 
phosphates structures. 
 
	
Figure	55:	FESEM	image	of	ZnO	soaked	with	eMEM	(left)	and	ZnO	soaked	with	SBF	(right)	
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4.3.3	X-Ray	Diffraction	(XRD)	
	
Concerning the samples soaked with eMEM, XRD analyses have been 
performed onto 5 porous ZnO samples. The one corresponding to the 1h soaking 
time is missing since it was damaged during ATR-IR analysis.  
 
Figure 56 report the results obtained for the 5h, 1D, 2D and 3D soaking time 
samples.  
	
	Figure	56:	XRD	pattern	of	porous	ZnO	samples	soaked	in	eMEM	
	
	
Table	11:	XRD	peaks	position	of	ZnO	samples	soaked	in	eMEM	
	
 2θ position  
Sample ZnO (100) ZnO (002) ZnO (101) ZnO (102) ZnO (110) Si 
5h 31.88º 34.50º 36.35º 47.70º 56.73º 33.12º 
1D 31.88º 34.54º 36.35º 47.67º 56.70º - 
2D 31.83º 34.48º 36.35º 47.61º 56.65º - 
3D  31.80º 34.46º 36.32º 47.61º 56.67º 33.00º 
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The results show that the crystal structure remains the same. Also, in these 
analyses no HAp-related peak was expected since no calcium phosphates could 
be formed in eMEM. 
	
	
	
4.3.4	Inductively	Coupled	Plasma	(ICP)	mass	spectrometry 
 
When soaking porous ZnO samples in eMEM, it is found that the evolution of P 
and Ca concentrations is very unstable. At a first point it slightly increases, then 
decreases along the first day, and finally increases again along the last two days, 
approaching values similar to the starting ones. This final increase can be 
possibly linked to the dissolution of Zn in the following figure: since the surface 
dissolves, it can release not only Zn2+ cations, but also ZnO and Zn(PO4)2 
structures, and what is detected by ICP is an overall increase of Zn and P in the 
solution. While Ca evolution is really small (between 350 and 400 ppb), P 
evolution is bigger. 
 
On the other hand, the evolution of Zn2+ versus time shows an important increase, 
due to the biodegradation of the sample, when soaking it in eMEM. 
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Figure	57:	ICP	results	when	evaluating	the	evolution	of	Ca	and	P	of	the	medium	for	cells	culture	among	
the	time	
	
 
	
	
Figure	58:	ICP	results	when	evaluating	the	evolution	of	Zn	of	the	medium	for	cells	culture	among	the	time	
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4.4	Uptaking/releasing	Rhodamine-β	dye	molecule	on	porous	ZnO	structures	for	
drug	delivery	applications	
	
As introduced in Paragraph 3.4, Rhodamine-B dye was used in this thesis work 
as a model for studying the capacity of the porous ZnO thin films to uptake and 
release molecules for future drug delivery applications. 
 
The experiments were done using two porous ZnO samples. The uptake 
experiment was performed on both and then, one was used for the release 
experiment and the other for obtaining the fluorescence images. 
	
For the uptake experiment, the characteristic absorption peak at the specific 
wavelength of 552 nm was monitored. Therefore, if Rhodamine-B was loaded on 
the porous ZnO sample, the intensity of the characteristic peak was expected to 
decrease, since the intensity depends on the amount of Rhodamine still present 
in the solution surrounding the ZnO sample. So, to evaluate the loading of 
Rhodamine against time, the decrease of the absorption intensity at 552 nm 
against time by analysing the UV spectrum of different Rhodamine solutions was 
performed. 
 
After leaving the sample into a flask covered with aluminium paper stirring at 
600rpm for 24h at room temperature, and collecting different aliquots of 
Rhodamine solution after 1h, 2h, 3h, 4h 5h and 24h, the results shown in Figure 
59 were obtained.  
		
	
66	
	
 
Figure	59:	Absorption	spectrum	of	Rhodamine-B	in	the	presence	of	porous	ZnO	thin	films	at	different	
time	interval	
 
All the absorbance values corresponding to 552 nm characteristic peak are 
tabulated in Table 12. 
 
The starting solution (SS) is also tabulated in order to evaluate the percentage of 
Rhodamine loaded on the porous ZnO sample versus time. 
 
 
 
 
 
 
 
 
Sample SS 1h 2h 3h 4h 5h 24h 
552 nm 0.173 0.161 0.163 0.159 0.158 0.153 0.161 
Table	12:	Amount	of	Rhodamine-B	at	552	nm	
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It was expected to be reduced among the time, following the 1h-2h-3h-4h-5h-24h 
order, as the sample was supposed to uptake more and more Rhodamine-B each 
hour. The fact that 2h and 24h values are in those position indicates that the 
problem of the base line is clearly present. However, for the 24h value, it could 
be also possible that after the prolonged time of soaking the sample in the 
Rhodamine solutions for 24h, part of the Rhodamine previously loaded on the 
sample surface has been desorbed, coming back to the solution, and inducing 
the increase of the absorption peak after 24h. 
 
The calibration curve obtained with Rod 2.5ppm diluted in water was normalized 
and the results is shown in Figure 60. The linearization of those results is plotted 
in red and was used for obtaining the concentration of Rhodamine at each period 
of time.  
 
	
Figure	60:	Calibration	curve	of	Rhodamine	2.5	ppm	diluted	in	H2O	normalized 
 
By combining the absorbance values at 552 nm wavelength found in Table 12 
with the linear fit of the calibration curves normalized, it is possible to quantiavely 
estimate the amount of Rhodamine uptaken.  
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In Figure 61 there are shown, on one hand, the concentration of Rhodamine in 
solution and, on the other hand, the percentage of Rhodamine that the sample 
have uptake. Those values are opposite due to the fact that with this experiment 
the results obtained are from the solution but the uptake values are the difference 
between the maximum (2.5 ppm) and the concentration ate the different time 
points.	
 
	
Figure	61:	Concentration	of	Rhodamine	in	solution	and	degree	of	uptaking	
	
Knowing that for the starting solution of Rhodamine with concentration of 2,5 
ppm, the amount of Rhodamine is 5,6 μmol, the amount of Rhodamine uptaken 
from porous ZnO thin film by means of percentage and µmol is reported in Table 
13. 
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 Sample SS 1h 2h 3h 4h 5h 24h 
% 0 28,8 27,2 29,6 30,4 33,2 28,8 
µmol 0 1,61 1,52 1,66 1,7 1,86 1,61 
	
Table	13:	Amount	of	Rhodamine	uptaken	from	porous	ZnO	thin	film	by	means	of	percentage	(%)	and	
µmol 
	
Concerning the release experiment, after leaving the sample (previously used for 
the uptake experiment) into a brownish plastic tube filled with 20 ml of SBF 
solution and a magnetic stirrer, stirring at 150 rpm with a constant temperature of 
37ºC, 100μl of the solution were extracted at each selected time point in order to 
analyse the UV spectrum of the different SBF solution samples. 
 
While Rhodamine was released from the sample to the solution, the characteristic 
peak at the specific wavelength of 552 nm was expected. If Rhodamine-B would 
have been released from the sample to the solution, the intensity of the 
characteristic would be expected to increase, since the intensity depends on the 
amount of Rhodamine present in the solution surrounding the ZnO sample.  The 
higher the absorption of this peak, the higher the amount of released Rhodamine 
from the sample. 
 
The results are shown in Figure 62. 
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Figure	62:	Release	spectrum	of	Rhodamine-B	in	presence	of	porous	ZnO	thin	films	at	different	time	
intervals	
	
 
Those results show a slight peak at 552 nm wavelength position related to 
Rhodamine-B release. This peak begins to be noticed after only leaving the 
sample for 5 min and increases among the time.  
 
All the absorbance values corresponding to 552 nm characteristic peak are 
tabulated in Table 14. 
 
 
 
 
Sample SS 5min 15min 30min 1h 2h 4h 6h 24h 48h 72h 1week 
552 nm 0.173 0.045 0.047 0.053 0.051 0.053 0.057 0.059 0.061 0.061 0.071 0.075 
Table	14:	Amount	of	Rhodamine-B	at	552	nm		
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The results of the calibration curve obtained with SBF diluted in water normalized 
are shown in Figure 63. The linearization of those results is plotted in red and 
used for obtaining the concentration of Rhodamine at each period of time. 
	
Figure	63:	Calibration	curve	of	SBF	diluted	in	H2O	normalized 
 
Again, by combining the absorbance values at 552 nm wavelength found in Table 
14 with the linear fit of the calibration curve normalized, it is possible to 
quantiavely estimate the amount of Rhodamine released.  
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Figure	64:	Concentration	of	released	Rhodamine	and	degree	of	release	
	
In Figure 64 there are shown, on one hand, the concentration of released 
Rhodamine and, on the other hand, the degree of Rhodamine released. 	
 
For the starting solution of Rhodamine released in SBF, the amount of 
Rhodamine is 1,61 μmol, which is equal to the value of Rhodamine uptaken after 
24h, that is the effective amount of Rhodamine loaded on the ZnO sample. The 
amount of Rhodamine released from the porous ZnO thin films by means of 
percentage and μmol are tabulated in Table 15. 
 
 
 
 
Sample SS 5min 15min 30min 1h 2h 4h 6h 24h 48h 72h 1week 
% 0 12,5 17,4 32,7 27,8 32,7 42,9 48 52,6 52,6 78,1 88,1 
µmol 0 0,20 0,28 0,53 0,45 0,53 0,69 0,77 0,85 0,85 1,26 1,42 
Table	15:	Amount	of	Rhodamine	released	from	porous	ZnO	thin	film	by	means	of	percentage	(%)	and	µmol	
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Rhodamine dyes fluoresce and can thus be detected with instruments called a 
fluorescence microscope. In this thesis, for observing the capacity of porous ZnO 
thin films in uptaking Rhodamine-B, fluorescence images of the sample 
previously used for the uptaking experiment have been obtained by a Nikon 
Eclipse Ti fluorescence microscope. 
 
Figure 65 show the images taken when observing the red channel at 4x, 20x and 
40x, respectively.  
 
Rhodamine has been absorbed on most of the sample surface, while the brighter 
spots are probably due to the formation of Rhodamine aggregates onto the 
porous ZnO surface. 
 
From this images, which refers to the sample soaked in the Rhodamine solution 
for 24h, it is possible to confirm that Rhodamine has been loaded on the ZnO 
sample, at least on the surface.  
 
From these analyses we cannot know if the Rhodamine was loaded also 
internally to the porous ZnO structure or just on the surface. 
  
Figure	65:	Fluorescence	images	of	porous	ZnO	thin	films	after	the	uptake	experiment 
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Chapter	5.	Conclusions 
	
In this thesis, the bioactivity, biodegradation behaviour and uptake/release 
properties of porous ZnO thin films deposited by sputtering technique are 
reported and described. 
 
It is shown that when interacting with SBF, ZnO samples and ZnO samples 
coated with GO, are bioactive. The interaction of both families of samples with 
SBF solution induced the precipitation of HAp on the surface. Due to the ability 
of GO to promote biological interactions, ZnO samples coated with GO showed 
a better bioactive behaviour, with HAp precipitation manifesting earlier than those 
without GO coating. 
 
When observing the biodegradation behaviour by soaking the ZnO samples both 
in SBF and eMEM media, it is found that the crystal structure reminds exactly the 
same versus the soaking time. On the other hand, it is found that release of Zn2+ 
ions is strongly limited when coating the ZnO surface with GO. 
 
The investigation of porous ZnO thin films for drug delivery applications done 
using Rhodamine-B as a fluorescent dye successfully showed the ability of this 
material to uptake and further release molecules. Indeed, porous ZnO thin films 
were able to uptake molecules after shorts periods of time, and also to release 
those molecules in a controllable way, to a solution which has ions concentrations 
nearly equal to those of human blood plasma. Fluorescence microscopy images 
further confirmed the capacity of porous ZnO thin films to absorb molecules, at 
least on the surface. 
	
In conclusion, this thesis shows that porous ZnO thin films can be promising 
candidates for the development of novel ZnO-based biomaterials for tissue 
engineering and drug delivery applications. 
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